Black Titan (NASDAQ:BTTC – Get Free Report) and Vivakor (OTCMKTS:VIVKD – Get Free Report) are both small-cap technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, profitability and analyst recommendations.
Risk & Volatility
Black Titan has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500. Comparatively, Vivakor has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500.
Profitability
This table compares Black Titan and Vivakor’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Black Titan | N/A | N/A | N/A |
| Vivakor | -105.57% | -141.06% | -56.70% |
Valuation & Earnings
This table compares Black Titan and Vivakor”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Black Titan | $180,000.00 | 19.27 | -$4.71 million | ($2.95) | -0.11 |
| Vivakor | $104.42 million | 0.02 | -$110.23 million | ($624.00) | -0.00 |
Black Titan has higher earnings, but lower revenue than Vivakor. Black Titan is trading at a lower price-to-earnings ratio than Vivakor, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of current ratings and price targets for Black Titan and Vivakor, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Black Titan | 1 | 0 | 0 | 0 | 1.00 |
| Vivakor | 1 | 0 | 0 | 0 | 1.00 |
Insider & Institutional Ownership
12.3% of Vivakor shares are owned by institutional investors. 53.7% of Black Titan shares are owned by insiders. Comparatively, 12.2% of Vivakor shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Summary
Black Titan beats Vivakor on 8 of the 11 factors compared between the two stocks.
About Black Titan
Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.
About Vivakor
Vivakor, Inc. operates, acquires, and develops technologies and assets in the oil and gas industry and related environmental solutions in the United States and Kuwait. The company owns and operates a crude oil gathering, storage, and transportation facility in Delhi, Louisiana. It also owns a crude oil storage tank located near Colorado City, Texas. In addition, the company offers remediation of soil and the extraction of hydrocarbons, such as oil from properties contaminated by or laden with heavy crude oil and other hydrocarbon-based substances. The company was formerly known as NGI Holdings, LLC and changed its name to Vivakor, Inc. in April 2008. The company was incorporated in 2006 and is based in Dallas, Texas.
Receive News & Ratings for Black Titan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Black Titan and related companies with MarketBeat.com's FREE daily email newsletter.
